A Study of Guselkumab in the Treatment of Participants with Moderate to Severe Plaque-Type Psoriasis with Randomized Withdrawal and Retreatment

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-000720-18

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

• To evaluate the efficacy of guselkumab in the treatment of subjects with moderate to severe plaque-type psoriasis. • To assess the safety and tolerability of guselkumab in subjects with moderate to severe plaque-type psoriasis.


Critère d'inclusion

  • Moderate to severe plaque-type psoriasis